Daxor Corporation (DXR)
NASDAQ: DXR · Real-Time Price · USD
13.91
+0.46 (3.45%)
Oct 8, 2025, 9:30 AM EDT - Market open
Daxor Market Cap
Daxor has a market cap or net worth of $69.33 million as of October 8, 2025. Its market cap has increased by 59.08% in one year.
Market Cap
69.33M
Enterprise Value
67.28M
1-Year Change
59.08%
Ranking
Category
Stock Price
$13.91
Market Cap Chart
Since September 3, 1985, Daxor's market cap has increased from $30.27M to $69.33M, an increase of 129.07%. That is a compound annual growth rate of 2.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 67.02M | 80.06% |
| Dec 31, 2024 | 37.22M | -19.10% |
| Dec 29, 2023 | 46.01M | 17.82% |
| Dec 30, 2022 | 39.05M | -14.22% |
| Dec 31, 2021 | 45.52M | -6.35% |
| Dec 31, 2020 | 48.61M | 38.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |